Antibody

---

Source:Rabbit polyclonal anti-GST A1-1 polyclonal antibody. 

Immunogen:Recombinant human GST A1-1 expressed in E. coli.  

Specificity:Specific for the a-form of human and rat GST. Reacts with recombinant human GST A1–1. Does not react with m or p GST's.. 

Form:Rabbit Serum with >0.1% sodium azide added as preservative.  

Usage:Western Blot  

Packaging:0.1 ml 

Storage:Avoid freeze-thaw cycles. Aliquot and store at -20 degrees C  

Source:Rabbit polyclonal anti-GST M1-1 polyclonal antibody. 

Immunogen:Recombinant human GST A1-1 expressed in E. coli. 

Specificity:Specific for the m–form of human and rat GST. Reacts with recombinant human GST P1–1. Does not react with a or p GST's. 

Form:Rabbit Serum with >0.1% sodium azide added as preservative.  

Usage:Western Blot 

Packaging:0.1 ml 

Storage:Avoid freeze-thaw cycles. Aliquot and store at -20 degrees C 

Spec.: 1000 uL

Classification:Oxidative Damage (Poly. Ab).

Spec.: 20 ug

Classification:Oxidative Stress (Mono. Ab).

Spec.: 20 ug

Classification:Oxidative Stress (Mono. Ab).

Spec.: 100 uL 

Description: This antibody recognizes endothelial nitric oxide synthase (eNOS, 140 kDa) protein in human, rat and mouse. The immunogen used was bovine eNOS synthetic peptide (599 – 613) plus C-terminal Cys (PYNSSPRPEQHKSKYKC) conjugated to KLH. No cross-reactivity to iNOS or bNOS.

Spec.: 100 uL

Description: This antibody recognizes brain nitric oxide synthase (bNOS, 155 kDa) protein in bovine, primates, mouse and rat. The immunogen used was rat bNOS synthetic peptide (724 – 739) corresponding to the calmodulin-binding domain, plus C-terminal Cys (TKRRAIGFKKLAEAVKC) conjugated to KLH. Exhibits no cross reactivity to iNOS or eNOS.

Introduction:High motility group (HMG) proteins are transcription factors that are expressed during embryonic development, not in normal adult tissues. The HMGI family consists of 3 proteins, HMGI, HMGI(Y) and HMGA2 (also known as HMGI-C). Experiments with knockout HMGA2 -/- mice yielded a reduced body weight compared to wild-type HMGA2 +/+ mice, which indicates that HMGA2 plays a role in mammalian growth. Interest in HMGA2 has increased recently as it has been found that HMGA2 is expressed in neoplastic tissues and that it apparently has a role in control of cell growth, differentiation and tumorigenesis. HMGA2 is expressed in tumor tissue but not in normal tissue immediately adjacent to the tumor tissue. Studies in peripheral blood show that HMGA2 is not present in normal healthy donors, but is present in the blood of a subset of breast cancer patients. In general, the presence of HMGA2 in the peripheral blood of breast cancer patients has a correlation with poor survival and with a higher histologic grade of the tumor. (1,2,3)  

Introduction:High motility group (HMG) proteins are transcription factors that are expressed during embryonic development, not in normal adult tissues. The HMGI family consists of 3 proteins, HMGI, HMGI(Y) and HMGA2 (also known as HMGI-C). Experiments with knockout HMGA2 -/- mice yielded a reduced body weight compared to wild-type HMGA2 +/+ mice, which indicates that HMGA2 plays a role in mammalian growth. Interest in HMGA2 has increased recently as it has been found that HMGA2 is expressed in neoplastic tissues and that it apparently has a role in control of cell growth, differentiation and tumorigenesis. HMGA2 is expressed in tumor tissue but not in normal tissue immediately adjacent to the tumor tissue. Studies in peripheral blood show that HMGA2 is not present in normal healthy donors, but is present in the blood of a subset of breast cancer patients. In general, the presence of HMGA2 in the peripheral blood of breast cancer patients has a correlation with poor survival and with a higher histologic grade of the tumor. (1,2,3)  

Introduction:High motility group (HMG) proteins are transcription factors that are expressed during embryonic development, not in normal adult tissues. The HMGI family consists of 3 proteins, HMGI, HMGI(Y) and HMGA2 (also known as HMGI-C). Experiments with knockout HMGA2 -/- mice yielded a reduced body weight compared to wild-type HMGA2 +/+ mice, which indicates that HMGA2 plays a role in mammalian growth. Interest in HMGA2 has increased recently as it has been found that HMGA2 is expressed in neoplastic tissues and that it apparently has a role in control of cell growth, differentiation and tumorigenesis. HMGA2 is expressed in tumor tissue but not in normal tissue immediately adjacent to the tumor tissue. Studies in peripheral blood show that HMGA2 is not present in normal healthy donors, but is present in the blood of a subset of breast cancer patients. In general, the presence of HMGA2 in the peripheral blood of breast cancer patients has a correlation with poor survival and with a higher histologic grade of the tumor. (1,2,3)  

Introduction:High motility group (HMG) proteins are transcription factors that are expressed during embryonic development, not in normal adult tissues. The HMGI family consists of 3 proteins, HMGI, HMGI(Y) and HMGA2 (also known as HMGI-C). Experiments with knockout HMGA2 -/- mice yielded a reduced body weight compared to wild-type HMGA2 +/+ mice, which indicates that HMGA2 plays a role in mammalian growth. Interest in HMGA2 has increased recently as it has been found that HMGA2 is expressed in neoplastic tissues and that it apparently has a role in control of cell growth, differentiation and tumorigenesis. HMGA2 is expressed in tumor tissue but not in normal tissue immediately adjacent to the tumor tissue. Studies in peripheral blood show that HMGA2 is not present in normal healthy donors, but is present in the blood of a subset of breast cancer patients. In general, the presence of HMGA2 in the peripheral blood of breast cancer patients has a correlation with poor survival and with a higher histologic grade of the tumor. (1,2,3)